Finance

Senarai
601607:SHA
Shanghai Pharmaceuticals Holding Ord Shs A
CN¥16.70
-1.12%
(-0.19) 1H
13 Okt, 3:00:02 PTG GMT+8  ·   CNY
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 601607...
Buka
CN¥16.88
Tinggi
CN¥16.92
Rendah
CN¥16.62
Permodalan Pasaran
55.79B
Purata volum
9.98J
Volum
15.40J
Dividen
2.69%
Dividen suku tahunan
CN¥0.11
Tarikh tanpa dividen
18 Sep 2026
Nisbah H/P
12.97
tgi 52 mgu
CN¥18.56
rdh 52 mgu
CN¥15.01
EPS
CN¥1.29
Syer tertunggak
1.92B
Bilangan pekerja
49K
Buka
CN¥16.88
Tinggi
CN¥16.92
Rendah
CN¥16.62
Permodalan Pasaran
55.79B
Purata volum
9.98J
Volum
15.40J
Dividen
2.69%
Dividen suku tahunan
CN¥0.11
Tarikh tanpa dividen
18 Sep 2026
Nisbah H/P
12.97
tgi 52 mgu
CN¥18.56
rdh 52 mgu
CN¥15.01
EPS
CN¥1.29
Syer tertunggak
1.92B
Bilangan pekerja
49K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Perihal Shanghai Pharmaceuticals Holding Ord Shs A
CEO-
Pekerja48.6K
Diasaskan18 Jan 1994
Ibu pejabat-
Sektor-
Laman websphchina.com
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
73.48B
68.51B
75.26B
72.21B
Kos barangan yang dijual
66.03B
60.55B
67.17B
64.09B
Kos hasil
66.03B
60.55B
67.17B
64.09B
Perbelanjaan penyelidikan dan pembangunan
556.53J
824.53J
468.22J
502.64J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
4.70B
4.97B
4.59B
4.65B
Belanja kendalian
5.58B
5.91B
5.47B
5.55B
Jumlah belanja kendalian
71.60B
66.47B
72.63B
69.64B
Pendapatan kendalian
1.88B
2.04B
2.63B
2.57B
Pendapatan bukan kendalian lain
-84.84J
-63.65J
-47.88J
-7.43J
EBT termasuk item luar biasa
1.48B
1.52B
2.42B
3.21B
EBT tidak termasuk item luar biasa
1.61B
1.44B
2.27B
3.03B
Belanja cukai pendapatan
485.91J
534.14J
569.09J
720.64J
Kadar cukai berkesan
32.89%
35.10%
23.52%
22.43%
Belanja kendalian lain
129.62J
271.29J
132.16J
186.62J
Pendapatan bersih
688.20J
577.49J
1.42B
2.09B
Margin untung bersih
0.94%
0.84%
1.88%
2.89%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
206.57J
-
38.70J
873.52J
Belanja faedah
-393.02J
-470.36J
-347.64J
-358.39J
Belanja faedah bersih
-186.45J
-470.36J
-308.94J
515.13J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
2.26B
2.54B
3.12B
3.07B
Keuntungan atau kerugian daripada jualan aset
39.99J
-157.15J
-
-179.70J
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google